Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29850 | 179 | 28.9 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
389 | 3 | PEROXISOME//CARNITINE//JOURNAL OF INHERITED METABOLIC DISEASE | 30841 |
1504 | 2 | CARNITINE//L CARNITINE//TRIMETAZIDINE | 7543 |
29850 | 1 | MILDRONATE//MET 88//GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR | 179 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MILDRONATE | authKW | 6496778 | 29% | 73% | 52 |
2 | MET 88 | authKW | 1023535 | 3% | 100% | 6 |
3 | GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR | authKW | 852946 | 3% | 100% | 5 |
4 | MELDONIUM | authKW | 767642 | 5% | 50% | 9 |
5 | 3 2 2 2 TRIMETHYLHYDRAZINIUM PROPIONATE | authKW | 341178 | 1% | 100% | 2 |
6 | GAMMA BUTYROBETAINE | authKW | 255875 | 3% | 25% | 6 |
7 | LONG CHAIN ACYLCARNITINE | authKW | 227447 | 2% | 33% | 4 |
8 | 2 OXOGLUTARATE 2OG OXYGENASE | authKW | 170589 | 1% | 100% | 1 |
9 | ADAPTED TO COLD TION | authKW | 170589 | 1% | 100% | 1 |
10 | ANTI HYPERTROPHIC ACTION | authKW | 170589 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 535 | 33% | 0% | 59 |
2 | Cardiac & Cardiovascular System | 358 | 18% | 0% | 33 |
3 | Virology | 81 | 6% | 0% | 10 |
4 | Chemistry, Medicinal | 37 | 5% | 0% | 9 |
5 | Toxicology | 37 | 5% | 0% | 9 |
6 | Medicine, General & Internal | 32 | 8% | 0% | 14 |
7 | Biochemical Research Methods | 20 | 4% | 0% | 8 |
8 | Chemistry, Analytical | 12 | 5% | 0% | 9 |
9 | Behavioral Sciences | 11 | 2% | 0% | 4 |
10 | Sport Sciences | 10 | 2% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEM FREE RAD | 170589 | 1% | 100% | 1 |
2 | CHAIR INTERNAL DIS PEDIAT | 170589 | 1% | 100% | 1 |
3 | CHAIR THEORET CLIN BIOCHEM | 170589 | 1% | 100% | 1 |
4 | CHAIR THER YSTOMATOL | 170589 | 1% | 100% | 1 |
5 | EOC MED COMMISS | 170589 | 1% | 100% | 1 |
6 | METABOL CARDIOVASC DRUG DISCOVERY | 170589 | 1% | 100% | 1 |
7 | MYASNIKOV FGBU RUSSIAN CARDIOL | 170589 | 1% | 100% | 1 |
8 | PYATIGORSK STATE MEDICOPHARMACEUT | 170589 | 1% | 100% | 1 |
9 | UMR 866EQUIPE PHYSIOPATHOL DYSLIPIDEMIES | 170589 | 1% | 100% | 1 |
10 | SOCIAL SCI MANAGEMENT BUSINESS ADM | 85294 | 1% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RUSSIAN JOURNAL OF CARDIOLOGY | 23263 | 4% | 2% | 8 |
2 | VOPROSY VIRUSOLOGII | 7575 | 6% | 0% | 10 |
3 | MEDICINA-LITHUANIA | 2896 | 2% | 0% | 4 |
4 | KARDIOLOGIYA | 2604 | 6% | 0% | 10 |
5 | FUNDAMENTAL & CLINICAL PHARMACOLOGY | 1338 | 2% | 0% | 4 |
6 | INZINERINE EKONOMIKA-ENGINEERING ECONOMICS | 1271 | 1% | 0% | 2 |
7 | FARMAKOLOGIYA I TOKSIKOLOGIYA | 1261 | 2% | 0% | 3 |
8 | CNS DRUG REVIEWS | 1045 | 1% | 1% | 1 |
9 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 855 | 2% | 0% | 3 |
10 | PHARMACOLOGICAL REPORTS | 852 | 2% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MILDRONATE | 6496778 | 29% | 73% | 52 | Search MILDRONATE | Search MILDRONATE |
2 | MET 88 | 1023535 | 3% | 100% | 6 | Search MET+88 | Search MET+88 |
3 | GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR | 852946 | 3% | 100% | 5 | Search GAMMA+BUTYROBETAINE+HYDROXYLASE+INHIBITOR | Search GAMMA+BUTYROBETAINE+HYDROXYLASE+INHIBITOR |
4 | MELDONIUM | 767642 | 5% | 50% | 9 | Search MELDONIUM | Search MELDONIUM |
5 | 3 2 2 2 TRIMETHYLHYDRAZINIUM PROPIONATE | 341178 | 1% | 100% | 2 | Search 3+2+2+2+TRIMETHYLHYDRAZINIUM+PROPIONATE | Search 3+2+2+2+TRIMETHYLHYDRAZINIUM+PROPIONATE |
6 | GAMMA BUTYROBETAINE | 255875 | 3% | 25% | 6 | Search GAMMA+BUTYROBETAINE | Search GAMMA+BUTYROBETAINE |
7 | LONG CHAIN ACYLCARNITINE | 227447 | 2% | 33% | 4 | Search LONG+CHAIN+ACYLCARNITINE | Search LONG+CHAIN+ACYLCARNITINE |
8 | 2 OXOGLUTARATE 2OG OXYGENASE | 170589 | 1% | 100% | 1 | Search 2+OXOGLUTARATE+2OG+OXYGENASE | Search 2+OXOGLUTARATE+2OG+OXYGENASE |
9 | ADAPTED TO COLD TION | 170589 | 1% | 100% | 1 | Search ADAPTED+TO+COLD+TION | Search ADAPTED+TO+COLD+TION |
10 | ANTI HYPERTROPHIC ACTION | 170589 | 1% | 100% | 1 | Search ANTI+HYPERTROPHIC+ACTION | Search ANTI+HYPERTROPHIC+ACTION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DAMBROVA, M , MAKRECKA-KUKA, M , VILSKERSTS, R , MAKAROVA, E , KUKA, J , LIEPINSH, E , (2016) PHARMACOLOGICAL EFFECTS OF MELDONIUM: BIOCHEMICAL MECHANISMS AND BIOMARKERS OF CARDIOMETABOLIC ACTIVITY.PHARMACOLOGICAL RESEARCH. VOL. 113. ISSUE . P. 771 -780 | 41 | 65% | 3 |
2 | SCHOBERSBERGER, W , DUNNWALD, T , GMEINER, G , BLANK, C , (2017) STORY BEHIND MELDONIUM-FROM PHARMACOLOGY TO PERFORMANCE ENHANCEMENT: A NARRATIVE REVIEW.BRITISH JOURNAL OF SPORTS MEDICINE. VOL. 51. ISSUE 1. P. 22 -+ | 37 | 69% | 0 |
3 | ZHU, Y , ZHANG, GY , ZHAO, J , LI, DS , YAN, XD , LIU, JF , LIU, XD , ZHAO, HB , XIA, JL , ZHANG, X , ET AL (2013) EFFICACY AND SAFETY OF MILDRONATE FOR ACUTE ISCHEMIC STROKE: A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE II MULTICENTER TRIAL.CLINICAL DRUG INVESTIGATION. VOL. 33. ISSUE 10. P. 755-760 | 17 | 71% | 5 |
4 | SJAKSTE, N , GUTCAITS, A , KALVINSH, I , (2005) MILDRONATE: AN ANTIISCHERNIC DRUG FOR NEUROLOGICAL INDICATIONS.CNS DRUG REVIEWS. VOL. 11. ISSUE 2. P. 151-168 | 19 | 70% | 24 |
5 | ZHANG, J , CAI, LJ , YANG, J , ZHANG, QZ , PENG, WX , (2013) NONLINEAR PHARMACOKINETIC PROPERTIES OF MILDRONATE CAPSULES: A RANDOMIZED, OPEN-LABEL, SINGLE- AND MULTIPLE-DOSE STUDY IN HEALTHY VOLUNTEERS.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 27. ISSUE 1. P. 120-128 | 11 | 73% | 5 |
6 | KUKA, J , VILSKERSTS, R , CIRULE, H , MAKRECKA, M , PUGOVICS, O , KALVINSH, I , DAMBROVA, M , LIEPINSH, E , (2012) THE CARDIOPROTECTIVE EFFECT OF MILDRONATE IS DIMINISHED AFTER CO-TREATMENT WITH L-CARNITINE.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS. VOL. 17. ISSUE 2. P. 215-222 | 16 | 50% | 3 |
7 | MAKRECKA, M , SVALBE, B , VOLSKA, K , SEVOSTJANOVS, E , LIEPINS, J , GRINBERGA, S , PUGOVICS, O , LIEPINSH, E , DAMBROVA, M , (2014) MILDRONATE, THE INHIBITOR OF L-CARNITINE TRANSPORT, INDUCES BRAIN MITOCHONDRIAL UNCOUPLING AND PROTECTS AGAINST ANOXIA-REOXYGENATION.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 723. ISSUE . P. 55-61 | 16 | 46% | 5 |
8 | AL TEMIMI, AHK , PIETERS, BJGE , REDDY, YV , WHITE, PB , MECINOVIC, J , (2016) SUBSTRATE SCOPE FOR TRIMETHYLLYSINE HYDROXYLASE CATALYSIS.CHEMICAL COMMUNICATIONS. VOL. 52. ISSUE 87. P. 12849 -12852 | 11 | 52% | 1 |
9 | LIEPINSH, E , MAKRECKA-KUKA, M , KUKA, J , VILSKERSTS, R , MAKAROVA, E , CIRULE, H , LOZA, E , LOLA, D , GRINBERGA, S , PUGOVICS, O , ET AL (2015) INHIBITION OF L-CARNITINE BIOSYNTHESIS AND TRANSPORT BY METHYL-GAMMA-BUTYROBETAINE DECREASES FATTY ACID OXIDATION AND PROTECTS AGAINST MYOCARDIAL INFARCTION.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 172. ISSUE 5. P. 1319 -1332 | 15 | 38% | 3 |
10 | GOGENS, C , GUDDAT, S , DIB, J , GEYER, H , SCHANZER, W , THEVIS, M , (2015) MILDRONATE (MELDONIUM) IN PROFESSIONAL SPORTS - MONITORING DOPING CONTROL URINE SAMPLES USING HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHY - HIGH RESOLUTION/HIGH ACCURACY MASS SPECTROMETRY.DRUG TESTING AND ANALYSIS. VOL. 7. ISSUE 11-12. P. 973 -979 | 9 | 64% | 1 |
Classes with closest relation at Level 1 |